0.001 0 (25%) 03-21 17:35 |
|
Open: | 0.000 |
High: | 0.001 |
Low: | 0.000 |
Pre. close: | 0.000 |
Volume: | 46,315,177 |
Avg. volume: | 43,757,174 |
MA (50): | 0.001 |
MA (200): | 0.052 |
Year high: | 1.200 |
Year low: | 0.000 |
Market cap: | 1(M) |
EPS: | 1.73 |
PE ratio: | 0 |
SELL | BUY |
HeikinAshi: | |
Kaufmans AMA: | |
Chandelier (20): | |
MA (5): | |
MA (50): | |
MACD (26,12,9): | |
Slow KDJ (14,3): | |
RSI (14): | |
CCI (20): |
Wed, 15 Mar 2023
Global Inflammatory Bowel Disease (IBD) Therapeutics Market to ... - GlobeNewswire
Tue, 07 Mar 2023
Pharnext Sa : New study published by Edison Investment Research updates valuation of Pharnext's assets - Marketscreener.com
Tue, 14 Feb 2023
TC BioPharm Announces New Chair of the Board, Arlene Morris - PR Newswire
Wed, 28 Dec 2022
Pharnext Strengthens its Ties With Néovacs to Secure the Next ... - AccessWire
Fri, 02 Dec 2022
Lupus nephritis: current perspectives and moving forward | JIR - Dove Medical Press
Tue, 08 Nov 2022
Hugo Brugière Joins Pharnext Board of Directors - AccessWire
©NovaStocks.com | euro Stocks quote, company news, stock charts, technical analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither NovaStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: Financial Modeling Prep
Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Third parties' use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.